Th22 cells and the intestinal mucosal barrier

Area of Science:

• Immunology
• Gastroenterology

Background:

• T-helper 22 (Th22) cells are a CD4+ T cell subset secreting IL-22 but not IL-17 or IFN-γ.
• Th22 cells and IL-22 are implicated in maintaining intestinal mucosal homeostasis, particularly in inflammatory bowel disease (IBD).

Purpose of the Study:

• To elucidate the impact of Th22 cells and IL-22 on intestinal mucosal barrier integrity.
• To review molecular characteristics, functional effects, and explore therapeutic strategies targeting Th22 and IL-22 pathways in IBD.

Main Methods:

• Literature review and synthesis of existing research on Th22 cells and IL-22.
• Analysis of molecular and functional data related to Th22 cells and IL-22 in the context of IBD.

Main Results:

• Th22 cells are a primary source of IL-22, a cytokine vital for mucosal healing and barrier function.
• The precise role of Th22 cells and IL-22 in IBD pathogenesis remains under investigation, with potential dual functions.

Conclusions:

• Understanding Th22 cell and IL-22 functions is critical for developing novel IBD therapies.
• Targeting the Th22/IL-22 axis offers promising therapeutic avenues for inflammatory bowel disease.